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Primary Cervical Adenocarcinoma With Intestinal
Differentiation and Colonic Carcinoma
Metastatic to Cervix
An Investigation Using Cdx-2 and a Limited Immunohistochemical Panel
Maria Rosaria Raspollini, MD; Gianna Baroni, BSc; Antonio Taddei, MD; Gian Luigi Taddei, MD
● Context.—Cdx-2 is expressed in normal colonic epithelia
and in most colorectal adenocarcinomas. No data exist on
Cdx-2 expression in primary cervical adenocarcinoma with
colonic differentiation.
Objective.—To ascertain the utility of Cdx-2 and a lim-
ited immunohistochemical panel in differentiating between
primary cervical adenocarcinoma with intestinal differen-
tiation and secondary (colonic) cervical adenocarcinoma,
which call for different surgical and chemotherapeutic
treatment protocols.
Design.—We examined cervical tract adenocarcinomas
in women with previously negative medical histories for
neoplastic disease and in women with colonic carcinoma.
An immunohistochemical panel consisting of cytokeratin
7, cytokeratin 20, carcinoembryonic antigen, and a new
marker, Cdx-2, was evaluated in all cases. The clinical data,
the morphologic features, and the immunohistochemical
staining patterns were compared.
Results.—Of the tumors diagnosed as metastatic intes-
tinal adenocarcinoma of the cervix, based on clinical data
and hematoxylin-eosin–stained sections, all were Cdx-2
positive, whereas Cdx-2 was not expressed in any of our
cases of primary cervical adenocarcinoma with colonic dif-
ferentiation. Carcinoembryonic antigen was expressed
both in primary cervical tumor and in secondary (intesti-
nal) cervical adenocarcinoma. Cytokeratin 20 was not ex-
pressed in our cases of cervical adenocarcinoma, and it
was not expressed in 7.15% of cervical metastases from
intestinal carcinoma. Immunostaining with cytokeratin 7
was positive in cervical adenocarcinoma, but was negative
in secondary (intestinal) cervical adenocarcinoma.
Conclusions.—Our immunohistochemical analysis
shows that Cdx-2 has good specificity and would be a good
marker to use in a limited panel of immunohistochemical
markers, such as cytokeratin 7, cytokeratin 20, and carci-
noembryonic antigen, to distinguish primary cervical ade-
nocarcinoma from intestinal metastases to the cervix.
(Arch Pathol Lab Med. 2003;127:1586–1590)
The incidence of adenocarcinoma of the cervix is vari-ously reported as accounting for 7% to 22% of cer-
vical malignancies.1 Adenocarcinoma of the cervix shows
a wide spectrum of glandular differentiation and is his-
tologically subtyped as mucinous, endometrioid, clear cell,
minimal deviation, well-differentiated villoglandular, se-
rous, and mesonephric. The mucinous type encompasses
several subgroups, including the most frequent, endocer-
vical adenocarcinomas, which constitute approximately
90% of cervical adenocarcinomas,2 as well as rare cases of
signet ring cell and intestinal cell types.3
Primary adenocarcinoma of the cervix with colonic dif-
ferentiation is very uncommon, and it is histologically in-
distinguishable from secondary (intestinal) cervical ade-
nocarcinoma.4–6 Certain features, however, including the
location of the tumor, its growth pattern, and clinical his-
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tory, have been suggested to be useful in distinguishing
secondary cervical tumors from primary cervical tumors.
While the impact of the histologic subtype on survival
is still a matter of dispute,7,8 the distinction between a pri-
mary neoplasm and a metastasis to the endocervix is em-
inently important for treatment and prognosis. Establish-
ing the histologic diagnosis of a tumor with an exclusive
intestinal morphology as primary or metastatic cervical
neoplasia on cervical biopsy may not always be possible
with routine light microscopy alone. For the clinician, this
differential diagnosis is essential in setting up different
treatment strategies. The medical history of the patient
and clinical workup with pelvic examination, measure-
ment of tumor markers (CA 125, carcinoembryonic antigen
[CEA], and CA 19.9), pelvic and abdominal ultrasonog-
raphy, and computed tomography of the pelvis and the
abdomen can lead pathologists to the correct diagnosis in
most cases.
Homeobox genes of the caudal family, CDX1 and CDX2,
are expressed in the intestinal epithelium.9 They are nec-
essary for intestinal organogenesis and encode for nuclear
transcription factors involved in proliferation and differ-
entiation of intestinal epithelial cells in fetal as well as
adult tissue.10 A recent study proposed a possible link be-
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tween Cdx-2 expression and colonic tumorigenesis.11 Cdx-
2 seems to be expressed in normal colonic epithelia and
most colorectal adenocarcinomas.12,13
The present study is based on 105 cases of cervical ad-
enocarcinoma; of these, 2 (1.9%) were primary cervical tu-
mors with colonic differentiation. We also analyzed 2605
cases involving women with intestinal carcinoma; in 14
(0.53%) of these cases, the cervical wall was infiltrated by
an intestinal carcinoma. We evaluated the usefulness of a
limited immunohistochemical panel consisting of cytoker-
atin 7 (CK7), cytokeratin 20 (CK20), CEA, and a new
marker, Cdx-2, for distinguishing between primary ade-
nocarcinoma with intestinal differentiation and cervical
metastasis of colonic adenocarcinoma.
MATERIALS AND METHODS
The files of the Department of Human Pathology and Oncology
of the University of Florence (Florence, Italy) were searched for
the period 1980 to 2002 for the diagnosis of primary cervical
adenocarcinoma. Of the 105 cases identified, we selected 2 cases
(1.9%) of mucinous adenocarcinoma with intestinal differentia-
tion. These 2 patients underwent cervical biopsy and subsequent-
ly abdominal hysterectomy with bilateral salpingo-oophorecto-
my and pelvic lymphadenectomy.
For the same period, department records contained surgical
specimens from 7139 patients with intestinal adenocarcinoma. Of
these 7139 cases, 2605 (36.48%) occurred in female patients, and
in 14 cases (0.53%), the patients underwent surgical treatment
consisting of colectomy with regional lymphadenectomy, appen-
dectomy, abdominal hysterectomy, bilateral salpingo-oophorec-
tomy, and omentectomy for intestinal tumor with uterine infil-
tration.
Clinical data available for each of the 14 patients with intestinal
carcinoma infiltrating the cervix and for 2 patients with primary
cervical adenocarcinoma included age, previous medical history,
surgical treatment, stage of disease, and follow-up information.
We derived staging information from surgical notes and pa-
thology reports. All neoplasms were staged according to a mod-
ified staging system of the International Federation of Gynecol-
ogy and Obstetrics (FIGO).14
The specimens were obtained by surgical resection in all cases
and were fixed in 10% formalin before being processed in par-
affin. Hematoxylin-eosin–stained sections from each histologic
specimen were reviewed by 2 pathologists to confirm the histo-
logic diagnosis. For the immunohistochemical analysis, a repre-
sentative section from each lesion was selected.
Immunohistochemical studies were performed using the strep-
tavidin-biotin-peroxidase method (UltraVision kit, Lab Vision,
Fremont, Calif) with diaminobenzidine as the chromogen and
hematoxylin as the nuclear counterstain. Antibodies included
anti-Cdx-2 (clone 7C7/D4; BioGenex, San Ramon, Calif; 1:100 di-
lution; with Immunocoloratore Genomix BioGenex and MW an-
tigen retrieval), anti-CK20 (clone IT-Ks20.8; BioGenex; 1:60 dilu-
tion; with Immunocoloratore Nexes Ventana and protease antigen
retrieval), anti-CK7 (clone OV-TL12/30; BioGenex; 1:800 dilution;
with Immunocoloratore Nexes Ventana and protease antigen re-
trieval), and anti-CEA (CD66e; clone 12-140-10; Novocastra, New-
castle upon Tyne, United Kingdom; 1:500 dilution; with Immu-
nocoloratore Nexes Ventana and protease antigen retrieval).
The negative control was performed by substituting the pri-
mary antibody with nonimmune mouse serum. Cases of conven-
tional mucinous cervical adenocarcinoma and intestinal carcino-
ma were used as positive controls for immunohistochemical
stains. Appropriate positive and negative controls were run si-
multaneously. The immunohistochemically stained sections were
evaluated without previous knowledge of the clinical outcome of
each patient. Brown staining of the nucleus with antibody-spe-
cific Cdx-2 was considered positive. Brown staining of the cyto-
plasm with antibody-specific CK20 and CK7 was considered pos-
itive. Lesions were considered immunoreactive with CEA if the
cytoplasm of columnar epithelial cells showed immunoreactivity
equal to glycocalyceal staining in intensity.
RESULTS
Cervical Metastases
Fourteen patients with colonic carcinoma and synchro-
nous cervical metastasis were studied. At the time of di-
agnosis, the women ranged in age from 47 to 76 years
(average, 62 years). Other than cervical and regional
lymph node metastasis, 5 women presented with ovarian
infiltration, and in 2 patients the liver was infiltrated as
well. The cervical tract metastases were detected during
the clinical workup of patients before surgery or during
the operation through careful examination of abdominal
and pelvic viscera. Histopathologic findings of the cervical
wall showed infiltrating ab extrinseco adenocarcinoma
with morphologic features indistinguishable from the pri-
mary colonic tumor.
Primary Cervical Tract Tumors
A 49-year-old woman presented with a history of meno-
metrorrhagia. Colposcopic examination revealed that the
cervical surface had been replaced by swollen nodosities
with atypical vessels. Vaginal examination and computed
tomography revealed that the lesion did not infiltrate the
parametrium. Tissue obtained by a cervical biopsy
showed a carcinoma with signet ring features. Based on
the morphologic features, an evaluation for an extragenital
tumor was performed prior to definitive treatment. Upper
gastrointestinal and sigmoidoscopy studies performed be-
fore surgery were negative for tumors, and the patient’s
breasts were normal to palpation and by mammography.
The woman underwent a radical hysterectomy with bilat-
eral salpingo-oophorectomy and a bilateral pelvic lymph-
adenectomy. During the operation, no evidence of extra-
genital tumor was found. The endocervical canal was
completely obliterated by a tan tumoral mass, which ex-
tended deep into the cervical wall. Histopathologic find-
ings showed an infiltrating carcinoma. The tumor cells
had vacuolated cytoplasm and small angulated nuclei,
which were displaced to the periphery of the cell. A single
large intracytoplasmic vacuole occupied the cytoplasm of
most cells. A diagnosis of primary cervical adenocarci-
noma of signet ring type was made on the basis of the
clinical and histologic data. The tumor was classified as
FIGO stage IIA. The patient received postoperative pelvic
irradiation.
A 23-year-old woman presented with a history of post-
coital vaginal bleeding and menometrorrhagia. Colpo-
scopic examination revealed that the entire cervical sur-
face had been replaced by a wide and ulcerative lesion,
and computed tomography revealed that the lesion infil-
trated the parametrium. Tissue obtained by a fractional
curettage showed a well-differentiated mucinous adeno-
carcinoma that was composed of intestinal-type cells. Also
in this case, the histologic features of the cervical tumor
necessitated that an evaluation for the possible presence
of an extragenital tumor be performed before definitive
treatment. Upper gastrointestinal and sigmoidoscopy
studies performed before surgery were negative for tumor.
The diagnosis of primary cervical adenocarcinoma of in-
testinal type was made on the basis of the clinical and
histologic data. The tumor was classified as FIGO stage
III. The patient underwent preoperative chemotherapy
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Figure 1. Positive brown staining with antibody-specific anti–Cdx-2 in the cell nuclei of a colorectal adenocarcinoma metastasis in the cervical
wall. A, Low-power view shows a glandular tumor with diffuse positive Cdx-2 staining infiltrating the cervix, while the squamous and glandular
cervical epithelium are Cdx-2 negative (original magnification 35). B, High-power view shows intensely positive Cdx-2 staining in the cell nuclei
of intestinal carcinoma (original magnification 340).
and subsequent radical hysterectomy and bilateral pelvic
lymphadenectomy.
Immunohistochemistry
Of the 14 tumors diagnosed as metastatic intestinal ad-
enocarcinoma of the cervix (based on clinical data and
hematoxylin-eosin–stained sections), all were positive for
Cdx-2 (Figure 1) and CEA, and all were negative for CK7.
Immunostaining with CK20 was positive in 13 cases
(92.85%), but negative in 1 case (7.15%). The primary in-
testinal adenocarcinoma had the same pattern of immu-
nohistochemical staining. Both intestinal and signet ring–
type endocervical primary adenocarcinomas were positive
for CK7 and CEA, but reactions for Cdx-2 and CK20 were
completely negative (Figures 2 and 3, respectively) (Table).
COMMENT
The most common sites of metastatic involvement of co-
lorectal carcinoma are regional lymph nodes and liver.
Other relatively common metastatic sites include perito-
neum, lung, and ovaries.15 Apart from local pelvic tumor
extension, metastatic cancer to the cervix is extremely rare,
as shown in our data, accounting for 0.3% of all patients
who die of cancer.16
Colonic differentiation features of carcinoma of the cer-
vix are most commonly seen in metastatic lesions from
the breast, large bowel, bladder, and stomach,17–21 whereas
primary endocervical adenocarcinoma of intestinal22–25 or
signet ring types26–28 are very rare.
Symptoms relating to a primary carcinoma may remain
clinically silent until months or years after the presenta-
tion of metastatic disease, and diagnosis of primary tu-
mors with unusual morphologic features should be made
only after exclusion of the most frequent metastatic tu-
mors. Often the diagnosis of a metastatic tumor is missed
by the pathologist because the existence of a present or
prior tumor at another site is either not known or, if
known, disregarded.
Pathologists need to be extremely cautious when eval-
uating cervical tumors with intestinal differentiation, be-
cause determination of whether a tumor is primary or
metastatic has profound prognostic and therapeutic im-
plications. Because there is considerable overlap in the
morphologic features of primary and metastatic tumors,
the importance of establishing a differential diagnosis
based on histologic features has prompted a search for
immunohistochemical stains that can help distinguish
these 2 types of lesions. Carcinoembryonic antigen is a
highly glycosylated cell surface protein that is overex-
pressed in a variety of human tumors, including cervical,29
colorectal, gastric, pancreatic, ovarian, breast, and non–
small cell lung carcinomas.30. Cytokeratin 7 and CK20
have been suggested as immunohistochemical markers of
intestinal carcinoma (CK7 negative, CK20 positive), but
some colonic carcinomas express CK7.31 A recent study
reported that there are metastases from colorectal carci-
nomas with a CK7-positive/CK20-negative immunophe-
notype and with a CK7-positive/CK20-positive immu-
nophenotype, so this immunohistochemical staining is not
helpful for differential diagnosis.32
This study, which combined both morphologic and clin-
ical data and assessed the immunohistochemical proper-
ties of mucinous cervical adenocarcinomas with colonic
differentiation, was undertaken with the aim of determin-
ing whether the introduction of a new monoclonal anti-
body, Cdx-2, in a panel of immunohistochemical stains
can help in the differential diagnosis of cervical carcinoma
with intestinal differentiation and the most frequent in-
testinal metastatic cervical lesions, which show Cdx-2 nu-
clear positivity.33 At the moment, the literature contains
no data on Cdx-2 expression in primary intestinal or sig-
net ring cervical adenocarcinomas, and to our knowledge,
this is the first report on Cdx-2 expression in primary ad-
enocarcinoma of the cervix with colonic differentiation.
Our immunohistochemical data show that Cdx-2 is a
good marker to use in a limited immunohistochemical
panel to distinguish primary tumors from metastatic co-
lonic lesions. These immunohistochemical data, when cor-
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Figure 2. A, Signet ring cell cervical carcinoma forming solid cell nests surrounded by pools of mucus (hematoxylin-eosin, original magnification
340). B, Immunostaining with anti–Cdx-2 antibody shows negative reaction in signet ring cell nuclei (original magnification 340). Immunostaining
with anti–cytokeratin 7 antibody (C) (original magnification 340) and with anti–carcinoembryonic antigen antibody (D) (original magnification
340) shows positive signet ring cells. E, Immunostaining with anti–cytokeratin 20 antibody shows negative signet ring cells (original magnification
340).
Figure 3. A, Cervical adenocarcinoma with intestinal differentiation (hematoxylin-eosin, original magnification 340). B, Immunostaining with
anti–Cdx-2 antibody shows negative cell nuclei (original magnification 340). Immunostaining with anti–cytokeratin 7 antibody (C) (original mag-
nification 340) and with anti–carcinoembryonic antigen antibody (D) (original magnification 340) shows positive cells. E, Immunostaining with
anti–cytokeratin 20 antibody (E) (original magnification 340) shows negative cells.
Immunohistochemistry Results
Tumor Type
Cdx-2,
No. of
Cases Positive
Cytokeratin 7,
No. of
Cases Positive
Cytokeratin 20,
No. of
Cases Positive
Carcinoembryonic
Antigen, No. of
Cases Positive
Metastatic colonic adenocarcinoma (n 5 14
cases) 14 0 13 14
Primary cervical adenocarcinoma with colon-
ic differentiation (n 5 2 cases) 0 2 0 2
Primary cervical adenocarcinoma (n 5 103
cases) 0 103 0 103
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related with clinical history and comparison of morphol-
ogy, are important in establishing the correct diagnosis,
which entails different therapeutic approaches. Our re-
sults also indicate the necessity of investigating the Cdx-
2 marker on other primary cervical adenocarcinomas with
intestinal differentiation.
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